Thomas J. Conlon

6.7k total citations · 1 hit paper
85 papers, 4.8k citations indexed

About

Thomas J. Conlon is a scholar working on Molecular Biology, Genetics and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Thomas J. Conlon has authored 85 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Molecular Biology, 39 papers in Genetics and 12 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Thomas J. Conlon's work include Virus-based gene therapy research (37 papers), Retinal Development and Disorders (13 papers) and Viral Infections and Immunology Research (10 papers). Thomas J. Conlon is often cited by papers focused on Virus-based gene therapy research (37 papers), Retinal Development and Disorders (13 papers) and Viral Infections and Immunology Research (10 papers). Thomas J. Conlon collaborates with scholars based in United States, Ireland and France. Thomas J. Conlon's co-authors include Barry J. Byrne, Terence R. Flotte, William W. Hauswirth, Sanford L. Boye, Sharon Schwartz, Tomás S. Alemán, Samuel G. Jacobson, Shalesh Kaushal, Artur V. Cideciyan and Lili Wang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Circulation Research.

In The Last Decade

Thomas J. Conlon

78 papers receiving 4.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Treatment of Leber Congenital Amaurosis Due to RPE65 Mutations by Ocular Subretinal Injection of Adeno-Associated Virus Gene Vector: Short-Term Results of a Phase I Trial

2008 772 citations William W. Hauswirth, Thomas J. Conlon et al. Human Gene Therapy profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas J. Conlon United States	33	3.3k	2.2k	646	531	518	85	4.8k
Lisbeth Tranebjærg Denmark	43	3.6k 1.1×	2.3k 1.0×	156 0.2×	643 1.2×	407 0.8×	163	6.7k
Christian Gilissen Netherlands	47	4.6k 1.4×	4.4k 2.0×	175 0.3×	459 0.9×	177 0.3×	135	8.5k
P. Pearson Netherlands	55	6.3k 1.9×	4.7k 2.1×	183 0.3×	771 1.5×	527 1.0×	209	10.7k
Alfons Meindl Germany	37	3.4k 1.0×	2.0k 0.9×	410 0.6×	549 1.0×	256 0.5×	76	5.7k
John R.W. Yates United Kingdom	33	2.2k 0.7×	1.5k 0.6×	1.2k 1.9×	169 0.3×	145 0.3×	82	5.4k
Hélène Dollfus France	42	4.8k 1.4×	3.0k 1.3×	1.2k 1.9×	482 0.9×	66 0.1×	178	6.7k
Dalil Hamroun France	24	2.1k 0.6×	976 0.4×	91 0.1×	361 0.7×	414 0.8×	60	3.5k
Martijn H. Breuning Netherlands	50	6.2k 1.9×	5.9k 2.6×	71 0.1×	476 0.9×	318 0.6×	160	11.0k
Norio Niikawa Japan	52	5.2k 1.6×	4.9k 2.2×	107 0.2×	170 0.3×	133 0.3×	306	9.3k
J Frézal France	31	4.7k 1.4×	1.4k 0.6×	426 0.7×	331 0.6×	165 0.3×	210	6.7k

Countries citing papers authored by Thomas J. Conlon

Since Specialization

Citations

This map shows the geographic impact of Thomas J. Conlon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas J. Conlon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas J. Conlon more than expected).

Fields of papers citing papers by Thomas J. Conlon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas J. Conlon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas J. Conlon. The network helps show where Thomas J. Conlon may publish in the future.

Co-authorship network of co-authors of Thomas J. Conlon

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas J. Conlon. A scholar is included among the top collaborators of Thomas J. Conlon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas J. Conlon. Thomas J. Conlon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Picciotto, Sabrina, Giorgia Adamo, Angela Paterna, et al.. (2025). Optimizing sustainable production of high-quality microalgae-derived extracellular vesicles through batch-refeed perfusion cultivation. Journal of Biotechnology. 406. 236–243. 1 indexed citations

Conlon, Thomas J. & Nicolas Touzet. (2025). Bioactive metabolites and extracellular vesicles from the marine chlorophyte genus Tetraselmis: Review. Biotechnology Advances. 83. 108662–108662.

Conlon, Thomas J., et al.. (2024). The effects of trophic mode and medium composition on the biochemical profile and antioxidant capacity of Tetraselmis chuii (CCAP 66/21B). Biocatalysis and Agricultural Biotechnology. 61. 103362–103362. 6 indexed citations

Estrada, Amara H., et al.. (2020). Functional Consequences of PDK4 Deficiency in Doberman Pinscher Fibroblasts. Scientific Reports. 10(1). 3930–3930. 9 indexed citations

Song, Chunjuan, Thomas J. Conlon, Wen‐Tao Deng, et al.. (2018). Toxicology and Pharmacology of an AAV Vector Expressing Codon-Optimized RPGR in RPGR-Deficient Rd9 Mice. PubMed. 29(4). 188–197. 16 indexed citations

Corti, Manuela, Barbara K. Smith, Lee Ann Lawson, et al.. (2017). Safety of Intradiaphragmatic Delivery of Adeno-Associated Virus-Mediated Alpha-Glucosidase (rAAV1-CMV- hGAA ) Gene Therapy in Children Affected by Pompe Disease. PubMed. 28(4). 208–218. 90 indexed citations

Guggino, William B., Janet M. Benson, JeanClare Seagrave, et al.. (2017). A Preclinical Study in Rhesus Macaques for Cystic Fibrosis to Assess Gene Transfer and Transduction by AAV1 and AAV5 with a Dual-Luciferase Reporter System. PubMed. 28(3). 145–156. 18 indexed citations

Ye, Guojie, Thomas J. Conlon, Kirsten Erger, et al.. (2015). Safety and Biodistribution Evaluation of rAAV2tYF-CB-hRS1, a Recombinant Adeno-Associated Virus Vector Expressing Retinoschisin, in RS1-Deficient Mice. PubMed. 26(3). 177–184. 20 indexed citations

Corti, Manuela, Brian Cleaver, Nathalie Clément, et al.. (2015). Evaluation of Readministration of a Recombinant Adeno-Associated Virus Vector Expressing Acid Alpha-Glucosidase in Pompe Disease: Preclinical to Clinical Planning. PubMed. 26(3). 185–193. 79 indexed citations

10.

Byrne, Barry J., Barbara K. Smith, Cathryn Mah, et al.. (2014). Phase I/II Trial of Diaphragm Delivery of Recombinant Adeno-Associated Virus Acid Alpha-Glucosidase (rAAV1-CMV- GAA ) Gene Vector in Patients with Pompe Disease. PubMed. 25(3). 134–163. 34 indexed citations

11.

Conlon, Thomas J., Wen‐Tao Deng, Kirsten Erger, et al.. (2013). Preclinical Potency and Safety Studies of an AAV2-Mediated Gene Therapy Vector for the Treatment of MERTK Associated Retinitis Pigmentosa. PubMed. 24(1). 23–28. 79 indexed citations

12.

Conlon, Thomas J., Kirsten Erger, Stacy Porvasnik, et al.. (2013). Preclinical Toxicology and Biodistribution Studies of Recombinant Adeno-Associated Virus 1 Human Acid α-Glucosidase. PubMed. 24(3). 127–133. 16 indexed citations

13.

Prabhakar, Shilpa, Davide Gianni, Thomas J. Conlon, et al.. (2012). Regression of Schwannomas Induced by Adeno-Associated Virus-Mediated Delivery of Caspase-1. Human Gene Therapy. 24(2). 152–162. 23 indexed citations

14.

Lee, Ni‐Chung, Darin J. Falk, Barry J. Byrne, et al.. (2012). An acidic oligopeptide displayed on AAV2 improves axial muscle tropism after systemic delivery. PubMed. 10(1). 3–3. 4 indexed citations

15.

Specht, Andrew J., Kirsten Erger, Travis Cossette, et al.. (2011). Glycogen Storage Disease Type Ia in Canines: A Model for Human Metabolic and Genetic Liver Disease. BioMed Research International. 2011(1). 646257–646257. 8 indexed citations

16.

Byrne, Barry J., Darin J. Falk, Christina A. Pacak, et al.. (2011). Pompe disease gene therapy. Human Molecular Genetics. 20(R1). R61–R68. 72 indexed citations

17.

Mendell, Jerry R., Louise R. Rodino‐Klapac, Janaiah Kota, et al.. (2009). Limb‐girdle muscular dystrophy type 2D gene therapy restores α‐sarcoglycan and associated proteins. Annals of Neurology. 66(3). 290–297. 163 indexed citations

18.

Pacak, Christina A., Thomas J. Conlon, Cathryn Mah, & Barry J. Byrne. (2008). Relative persistence of AAV serotype 1 vector genomes in dystrophic muscle. PubMed. 6(1). 14–14. 16 indexed citations

19.

Conlon, Thomas J., et al.. (2007). Rapid, widespread transduction of the murine myocardium using self-complementary Adeno-associated virus. PubMed. 5(1). 13–13. 15 indexed citations

20.

Whitman, Warren C., et al.. (1962). Results of clipping trials with grasses and grass-alfalfa mixtures.. 22(3). 4–13. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact